Patents
Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)
11/2005
11/24/2005US20050261259 Phytosterol and/or phytostanol derivatives
11/23/2005CN1699397A Process for preparing notoginseng triol saponin and use thereof
11/23/2005CN1699396A Process for preparing notoginseng diol saponin
11/23/2005CN1228343C Substance having steroid-like structure, process for production thereof and antitumor agents containing same
11/22/2005US6967195 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent
11/17/2005US20050256093 Branched polyamine steroid derivatives
11/16/2005EP1248768B1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
11/16/2005CN1696144A Technique for preparing malonyl ginsenoside, and application of medication in treating diabetes
11/16/2005CN1227259C Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism
11/16/2005CN1227212C Method for preparing fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry
11/10/2005US20050250953 Phytosterols, squalene and Vitamin E are recovered from phytonutrients concentrate derived from crude palm oil via esterification, transesterification, vacuum distillation, saponification, crystallization and organic solvent paretitioning
11/09/2005CN1226303C High yield separating method for ginseng saponin Rb1
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962909 Treatment of neovascularization disorders with squalimine
11/01/2005CA2459351C Methods for treating deodorizer distillate
10/2005
10/27/2005WO2005079164A3 5α-REDUCTASE INHIBITORS
10/26/2005EP1063999B1 Epiallopregnanolone in the treatment of cns disorders
10/19/2005EP1585724A2 Method of reducing toxicity of retinoids
10/19/2005EP1585723A2 Modified retinoid compounds and their uses
10/19/2005CN1684971A Novel structures and compositions comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease, its underlying co
10/19/2005CN1683387A Method for extracting momordica glycoside from momordica grosvenori
10/18/2005US6956125 Partial glycerides are subjected to a first transesterification step under mild conditions and, after working up and the removal of impurities, the sterol esters are subjected to a second transesterification
10/13/2005WO2005095435A1 Method for producing pregnane derivative
10/13/2005WO2005094838A1 Drugs, foods and drinks for ameliorating hyperglycemia
10/13/2005US20050227954 Hypoglycemic agent
10/12/2005CN1679959A Liver targeted auxiliary material containing D-glactose and sterol and its use
10/06/2005WO2005058934A3 Glycosylated steroid derivatives with anti-migratory activity
10/06/2005US20050222098 Regulation of meiosis
10/05/2005CN1221564C Steride, its systhesis method and use
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
09/2005
09/29/2005WO2005090379A1 Compounds and sensor for detecion of polycyclic aromatic hydrocarbons
09/28/2005CN1220697C Pyloric spirobacterium inhibitor
09/27/2005US6949533 use in treating asthma, allergy, arthritis and thrombosis
09/22/2005US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction
09/21/2005CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
09/21/2005CN1219790C C60 glucocorticoid and it use
09/14/2005EP1572715A1 Steroid compounds with anti-tumor activity
09/14/2005CN1668631A Fractionation of phytosterol esters in oil
09/09/2005WO2005082925A2 Novel steroid agonist for fxr
09/07/2005EP1404901B1 Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof
09/01/2005WO2005079164A2 5α-REDUCTASE INHIBITORS
08/2005
08/31/2005EP1568706A1 Novel steroid agonist for FXR
08/31/2005EP1392714B1 Steroids as agonists for fxr
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1660885A Sulfonated sterol, preparing method and application
08/31/2005CN1216861C Crystals of vitamin D derivatives and process for the preparation thereof
08/31/2005CN1216607C Neurotoxicity inhibiting compsns. contg. ginsenoside Rg3 or ginsenoside Rh2 transferring glu
08/25/2005US20050187202 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/24/2005EP1504019B1 Platinum complexes having antitumor activity
08/24/2005EP1226156B1 Process for producing phytosterols by saponification in an alcohol/water solvent
08/24/2005CN1659174A Method of storing hydrogen, hydrogen inclusion compound and process for producing the same
08/24/2005CN1216065C Production method of oryzanol extracted by solvent extraction process
08/23/2005US6933383 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone.
08/18/2005WO2005023830A3 Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
08/18/2005CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
08/17/2005CN1655806A Treatment of diseases involving defective gap junctional communication
08/17/2005CN1215080C Substd. sapogenins and their use
08/11/2005US20050176976 GABA a modulating neurosteroids
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050175976 Meiosis activating sterol augments implantation rate
08/10/2005CN1653082A Platinum complexes having antitumor activity
08/10/2005CN1652794A Neuroprotective spirostenol pharmaceutical compositions
08/10/2005CN1651452A Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient
08/10/2005CN1651451A 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application
08/04/2005WO2005070949A1 Di-steroidal prodrugs of estradiol
08/04/2005WO2005070435A1 Agent for improving dynamic eyesight
08/04/2005US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity
08/04/2005CA2553815A1 Di-steroidal prodrugs of estradiol
08/03/2005EP1559720A1 Method of separating ergosterol
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005CN1649653A Methods for treating deodorizer distillate
08/02/2005US6924275 Aminophenol derivatives and their use in cosmetics
07/2005
07/27/2005EP1556406A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease
07/27/2005CN1646556A Blanched polyamine steroid derivatives
07/21/2005US20050159399 Reacting an estradiol with a linking goup slected from a carbonate, a polyoxyethylene glycol and succinic anhydride, an aliphatic diacid, a peptide linkage having 2-15 amia tert-butoxycarbonyl protected cysteic acidno acids
07/20/2005CN1211087C Competitive progesterone antagnoists for regulating female fertility as required
07/13/2005EP1551860A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
07/13/2005CN1639184A Process of extracting and purifying phytosterols and phytostanols from tall oil pitch
07/13/2005CN1637017A Crystals of a vitamin D derivative and a method for the preparation thereof
07/12/2005US6916835 Nitrate esters and their use for neurological conditions
07/06/2005EP1550433A1 Use of ecdysteroids for teh preparation of cosmetic or dermatologic compositions for avoiding the hair loss
07/06/2005CN1634970A Process for preparing notoginsen triterpenes
07/06/2005CN1634969A Cholestrin derivative as nucleoside analog
07/06/2005CN1634968A Process for extracting purified beta-sterol from concentrated residue of paclitaxel extraction
06/2005
06/30/2005WO2005058934A2 Glycosylated steroid derivatives with anti-migratory activity
06/30/2005US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
06/30/2005US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents
06/30/2005CA2549074A1 Glycosylated steroid derivatives with anti-migratory activity
06/29/2005EP1548025A2 Sapogenin derivatives and their use in the treatment of cognitive dysfunction
06/23/2005US20050137175 Composition with ecdysteroid with water or milk for lotions for skin and applying to prevent hair loss
06/22/2005CN1630528A Brain cell or nerve cell protecting agents comprising ginseng
06/22/2005CN1629179A Ganoderma lucidum sterol extract and its preparation process and application
06/14/2005US6905687 Fusion proteins; immunogens; solid phase synthesis; kits
06/09/2005WO2005005453A3 Novel compounds and compositions comprising sterols and/or stanols and cholesterol biosynthesis inhibitors and use thereof in treating or preventing a variety of diseases and conditions.
06/08/2005EP1537068A1 Materials and methods for treating hypercholesterolemia
06/08/2005CN1204892C Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid
06/02/2005WO2005049037A1 Process for preparing phytosterol dispersions for application in beverages
06/01/2005EP1534298A2 Novel anticholesterol compositions and method for using same
06/01/2005CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 49